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Abstract
Background
Previous studies evaluating the progression of the necrotic wave in relation to heart rate
were carried out only in animal models of ST-elevated myocardial infarction (STEMI). Aim
of the study was to investigate changes of myocardial salvage in relation to different heart
rates at hospital admission in timely reperfused patients with STEMI by using cardiovascu-
lar magnetic resonance (CMR).
Methods
One hundred-eighty-seven patients with STEMI successfully and timely treated with pri-
mary coronary angioplasty underwent CMR five days after hospital admission. According to
the heart rate at presentation, patients were subcategorized into 5 quintiles: <55 bpm
(group I, n = 44), 55–64 bpm (group II, n = 35), 65–74 bpm (group III, n = 35), 75–84 bpm
(group IV, n = 37),85 bpm (group V, n = 36). Area at risk, infarct size, microvascular
obstruction (MVO) and myocardium salvaged index (MSI) were assessed by CMR using
standard sequences.
Results
Lower heart rates at presentation were associated with a bigger amount of myocardial sal-
vage after reperfusion. MSI progressively decreased as the heart rates increased (0.54
group I, 0.46 group II, 0.38 group III, 0.34 group IV, 0.32 group V, p<0.001). Stepwise multi-
variable analysis showed heart rate, peak troponin and the presence of MVO were indepen-
dent predictor of myocardial salvage. No changes related to heart rate were observed in
relation to area at risk and infarct size.
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Conclusions
High heart rates registered before performing coronary angioplasty in timely reperfused
patients with STEMI are associated with a reduction in salvaged myocardium. In particular,
salvaged myocardium significantly reduced when heart rate at presentation is85 bpm.
Introduction
In patients with ST-elevated myocardial infarction (STEMI), timely reperfusion is able to pre-
serve part of the area at risk (AAR) from necrosis granting an amount of myocardial salvage
resulting from the difference between AAR and final infarct size (IS). Myocardial salvage can
be also modified by different factors, since for a same time of occlusion the quantity of myocar-
dial salvage can be different. It is important to better understand the determinants of progres-
sion of necrotic wave [1] to develop new reperfusion strategies able to maximize the salvaged
area and improve clinical parameters and prognosis [2, 3]. In last year's, several studies have
been carried out in animals demonstrating that higher heart rates during the acute phase of
STEMI were associated with larger myocardial damage, regardless of the time of coronary
occlusion [4,5,6]. Nevertheless, still there is a lack of evidence in humans, since for a long time,
histological examination has been the only existing technique to quantify the amount of sal-
vaged myocardium. Recently cardiac magnetic resonance (CMR) has been developed as a well
validated and reproducible technique allowing quantification of AAR, IS and myocardial sal-
vage in vivo [2, 3, 7, 8]. Myocardial salvage can be assessed in humans by comparing
T2-weighted (edematous myocardium) and late gadolinium enhancement (LGE) CMR images
[2, 3, 7, 8]. The aim of this study was to investigate the impact of heart rate, measured before
the recanalization, on myocardial damage assessed by CMR in patients with STEMI timely
reperfused by primary percutaneous coronary intervention (PPCI).
Methods
Study Population
One-hundred eighty seven consecutive patients with first STEMI undergoing PPCI within 6
hours after the onset of symptoms were prospectively enrolled in the study between January
2014 and February 2015. Heart rate was registered in the emergency room before any drug
administration and before reperfusion by a caliper on the diagnostic electrocardiogram. Tropo-
nin I measurement was also systematically performed at hospital admission, every 3 h for the
subsequent 24 h, and then every 12 h for the following 2 days. The CMR study was carried out
on day 5 after PPCI. Exclusion criteria were: acute administration of beta-blockers before
emergency room admission, atrial fibrillation, unsuccessful PPCI, rescue PCI, facilitated PCI,
Killip class III-IV, previous myocardial infarction, previous coronary artery bypass grafting,
and contraindications to CMR. Patients with hemodynamic instability at the time of CMR also
were excluded. All participants gave written informed consent to the protocol, and the study
was approved by the ethical committee of the Department of Cardiology, Policlinico Umberto
I, Roma Italy.
Coronary Angioplasty
PPCI and stenting of infarct related artery was performed in all patients according to the clini-
cal protocol used at our institution [9,10]. Thrombolysis in Myocardial Infarction (TIMI) flow
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grade was semi quantitatively scored as previously described [11]. The number of coronary ves-
sels demonstrating significant coronary artery disease was reported. A successful angioplasty
was defined a combination of post-procedural TIMI flow grade 3 and residual stenosis<30%.
Time to reperfusion was defined as the interval from the onset of symptoms to the first balloon
inflation. The grade of epicardial collaterals to the infarcted-related artery was evaluated
according to Rentrop et al.[12].
CMR Acquisition Protocol
CMR studies were performed with a 1.5-T unit Avanto Siemens, Erlangen, Germany. All stud-
ies were performed with the use of dedicated cardiac software, phased array surface receiver
coil, and ECG triggering. In brief, after determination of cardiac axes with localizers, breath-
hold steady state free-precession cine CMR was performed in cardiac vertical and horizontal
long-axis orientation and in short-axis orientation. In cardiac short-axis orientation, both ven-
tricles were completely encompassed by a stack of contiguous slices. Next, myocardial edema
imaging was performed with the use of breath-hold black-blood T2-weighted, short-inversion
time, inversion-recovery, fast spin-echo imaging (T2w imaging) in cardiac short-axis orienta-
tion. Finally, a breath-hold T1- weighted, 2-dimensional contrast-enhanced, inversion recov-
ery, segmented gradient-echo sequence was used to depict the presence, location, and extent of
IS (LGE imaging) and the concomitant presence of microvascular obstruction. An intravenous
contrast agent dose of 0.1 mmol/kg gadolinium-BOPTA (Multihance, Bracco, Milan, Italy)
was used. LGE imaging was performed between 10 and 20 minutes after contrast administra-
tion. Inversion time was individually adapted to nullify the signal of remote myocardium
(usual range, 220 to 300 ms). Technical details of these sequences are described elsewhere [2,
13, 14]
Image Analysis
All CMR studies were analyzed off-line by the use of a dedicated workstation (Siemens Argus,
Erlangen, Germany) by two experts (MF and IC) who had no knowledge of the patient identity.
Conflicts in data interpretation were resolved by consensus. Left ventricular volumes, systolic
function, and mass were calculated from the short-axis steady-state free precession cines.
Infarcted myocardial mass and microvascular obstruction (MVO) were manually traced and
calculated from the LGE short-axis images. As reported in Bondarenko et al. [15], myocardial
regions was considered infarcted if the IS signal intensity was>5 standard deviations above the
remote myocardium. The MVO was defined as a dark zone within the infarcted segments, usu-
ally located in the subendocardium. The mass of myocardial edema was traced and calculated
from the T2w-STIR images by the use of a similar threshold-based approach (signal intensity
>2 standard deviations of remote myocardium) [16]. Salvaged myocardium was quantified as
the difference between the area of increased T2w-STIR signal (area at risk) and the area of LGE
(IS), and myocardial salvage index (MSI) was calculated by normalizing MS for AAR as previ-
ously described [16–22]. All measurements were normalized to left ventricular (LV) mass.
Reproducibility of CMR data in our laboratory were previously described. [2, 14, 21, 23]
Statistical Analysis
Data were analyzed with SPSS software version 20.0 (SPSS Inc., Chicago, Illinois). Continuous
variables were calculated as average values considering standard deviation, whereas categorical
were calculated as percentages. Differences between means of continuous variables at different
times to reperfusion were analyzed by 1-way analysis of variance by the use of a linear trend
analysis; a post-hoc analysis with Bonferroni correction was made for differences between
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groups. The differences between categorical variables were analyzed with the chi-square test of
Pearson. A Student t test for independent groups was used to assess differences in continuous
variables between anterior versus non-anterior infarction, these tests were made without cor-
rection for multiple comparisons. Differences were considered statistically significant at a
2-sided p value<0.05. A multivariable logistic regression analysis was conducted considering
as dependent variable myocardial salvage index after reperfusion. The median value of MSI
detected in our study patients (= 0.41) was used to divide the whole population in two groups
(MSI< 0.41 and MSI> 0.41). All variables presenting a significant value>0.25 at univariate
analysis were included in the model. The stepwise method with backward elimination was
used, and odds ratios (ORs) with 95% CIs were calculated. The model was evaluated with Hos-
mer and Lemeshow test.
Results
Clinical and Angiographic Data
The minimal dataset of this study may be found in S1 Minidataset. Clinical and angiographic
data are summarized in Table 1. Coronary angioplasty was performed in left anterior descend-
ing artery (LAD) in 85 patients, in the right coronary artery in 83 patients, and in the left cir-
cumflex artery in 19 patients. Mean time from symptom onset to reperfusion was 152±149
min. No events suggesting reocclusion/stenosis were observed between PPCI and CMR exami-
nations. For the purpose of the study, patients were subcategorized into 5 quintiles on the basis
of the heart rate registered in the emergency room before the culprit lesion recanalization:<55
bpm (group I, n = 44), 55 to 64 bpm (group II, n = 35), 65 to 74 bpm (group III, n = 35), 75 to
Table 1. Patients characteristics categorized by heart rate at hospital presentation.
Variable Groups (n = 187 patients) Heart Rate p values
<55bpm (n = 44) 55-64bpm (n = 35) 65-74bpm (n = 35) 75–84 bpm (n = 37) 85bpm (n = 36)
Age 56±11 61±9 62±11 58±10 57±10 0.054
Sex (male) 36 (81%) 32 (91%) 26 (74%) 33 (89%) 30 (83%) 0.309
Hypertension 17 (39%) 6 (17%) 15 (42%) 17 (45%) 16 (44%) 0.093
Diabetes 4 (9%) 2 (5.9%) 3 (8.6%) 6 (16%) 6 (16%) 0.503
Smoking 30 (69%) 17 (51%) 15 (45%) 23 (65%) 22 (61%) 0.362
Dislipidemia 24 (55%) 21 (61%) 21 (60%) 23 (62%) 17 (47%) 0.686
Family history of CAD 21(48%) 14 (41%) 16 (45%) 14 (37%) 11 (30%) 0.527
Prodromal Angina 4 (9%) 3 (8.6%) 5 (16%) 6 (16%) 3(8%) 0.146
Time to treatment (min) 147±131 124±122 119±130 176±142 161±149 0.106
Peak Troponin I (ng/ml) 83±112 78±73 120±109 142±147 89±116 0.081
LAD v/s no LAD 13 (29%) 9 (25%) 19 (54%) 23 (62%) 21 (58%) 0.001
TIMI pre-PCI 2/3 14 (32%) 9 (25%) 8 (23%) 7 (18%) 7 (19%) 0.088
Rentrop grade 0.23°0.70 0.25°0.45 0.39°0.33 0.20°0.71 0.32°0.78 0.488
ACE inhibitors/ARB 21 (87%) 31 (90%) 34 (97%) 30 (83%) 31 (84%) 0.412
Beta-blockers 34 (78%) 30 (85%) 29 (82%) 27 (73%) 29 (78%) 0.846
Statins 40 (91%) 30 (85%) 33 (94%) 32 (91%) 31 (84%) 0.636
Data are presented as median ± SD or number (%)
CAD = coronary artery disease; LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery; MVO = microvascular obstruction;
PCI = percutaneous coronary intervention; RCA = right coronary artery; TIMI = Thrombolysis In Myocardial Infarction; CC = collateral circulation;
ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker. Time to treatment = time form symptom onset to balloon inflation.
doi:10.1371/journal.pone.0145495.t001
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84 bpm (group IV, n = 37), and 85 bpm (group V, n = 36). No differences on baseline clinical
and angiographic characteristics were observed between groups, except for LAD infarcts that
were more frequent in groups with higher heart rates (Table 1). In particular, no statistical dif-
ferences between groups were observed in time to PCI, incidence of risk factors, prodromal
angina, and TIMI score pre-PCI. The majority of patients showed TIMI flow 0–1 before coro-
nary angioplasty. Concomitant treatment after reperfusion was similar between groups.
(Table 1).
Heart Rate and Infarct Size, Myocardial Edema, Microvascular
Obstruction and Myocardial Salvage
An infarcted region on LGE images was visualized in 180 out of 187 patients, corresponded to
the infarct related artery territory distribution. Mean IS among groups was 17±12% of LVmass.
Not significant changes of IS over heart rate were found (13%, 16%, 21%, 19% and 16%, respec-
tively, p = 0.075) (Table 2; Fig 1). Increased signal intensity on T2w-STIR imaging (myocardial
edema) was observed in all patients. The mean size of edema among groups was 28±16% of LV
mass. In all patients, the location of T2w-STIR increased signal intensity corresponded to the ter-
ritory of infarct related artery distribution. The extent of myocardial edema did not change signif-
icantly as heart rate increased (29%, 29%, 32%, 28% and 23%, respectively, p = 0.217). (Table 2;
Fig 1). Also the presence of microvascular obstruction was similar between groups. Conversely,
the MSI significantly reduced as heart rate increased (0.54, 0.46, 0.38, 0.34 and 0.32 respectively,
p<0.001). In particular, a marked improvement in salvaged myocardium was observed as heart
rate was 55 bpm (group I vs. III, p = 0.017; group I vs. IV, p = 0.001; group I vs. V, p<0.001),
whereas a trend toward a larger amount of salvaged myocardium was observed between group II
vs. V (p = 0.101), and no significant changes were observed between groups III, IV and V
(Table 2; Fig 1). Dividing our study population into two groups according to HRmedian value, a
higher MSI value was found for heart rate<70 bpm (0.49±0.23 vs 0.33±0.22; p<0.001), whereas
AAR and IS showed no significant differences (30±16 vs 26±16; p = 0.124 and 16±11 vs 17±12;
p = 0.333 respectively). At multivariable analysis heart rate [OR 0.95 (95%CI: 0.92–0.97)
p = 0.001], peak troponin [OR 0.995 (95%CI: 0.991–0.998) p = 0.041] and the presence of MVO
Table 2. Cardiac magnetic resonance parameters after reperfusion categorized by heart rate at hospital presentation.
Variable Groups (n = 187 patients) Heart Rate p values
<55bpm (n = 44) 55-64bpm (n = 35) 65-74bpm (n = 35) 75–84 bpm (n = 37) 85bpm (n = 36)
AAR (%LV) 29±15 29±15 32±16 28±15 23±17 0.217
IS (%LV) 13±9 16±11 21±14 19±13 16±12 0.075
Presence of MVO 25 (56%) 22 (62%) 22 (62%) 16 (43%) 17 (47%) 0.316
MSI 0.54±0.22 0.46±0.21 0.38±0.20§ 0.34±0.24† 0.32±0.17‡• <0.001
LVEF 51±7.2 50±8.1 48±8.3 47±9.2 47±8.9 0.082
Data are presented as median ± SD or number (%)
§ p = 0.017 vs. group I
†p = 0.001 vs. group I
‡ p<0.001 vs. group I
• p = 0.101 vs. group II
AAR = Area at Risk; IS = Infarct Size; LV = Left Ventricle; MVO = Microvascular obstruction; MSI = myocardial salvage index; LVEF = Left Ventricular
Ejection Fraction
doi:10.1371/journal.pone.0145495.t002
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Fig 1. Bar graphs showing the influence of heart rate onmyocardial salvage (A), area at risk (B) and
infarct size (C) in patients categorized in quintiles according to heart rate at hospital admission
(details in the text).
doi:10.1371/journal.pone.0145495.g001
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[OR 0.2 (95%CI: 0.075–0.537) p<0.001] were independently associated with myocardial salvage
(Table 3).
Heart Rate and Infarct Location
The relation between infarct location and heart rate was depicted in Table 4. LAD infarcts were
associated to higher heart rates and they were more frequently found in groups III, IV and V
(29%, 25%, 54%, 62% and 58% respectively, p = 0.001). Notably, when LAD was occluded a
higher amount of edematous (32±17 vs. 25±14, p = 0.002) and necrotic (19±13 vs. 15±10,
p = 0.015) myocardium was found. On the opposite, MSI did not significantly change in rela-
tion the occlusion site (0.40±0.23 vs. 0.42±0.25, p = 0.672). (Table 4).
Table 3. Predictors of myocardial salvage in univariable and stepwise multivariable regression analysis.
Parameter Univariable Multivariable
P value Odds Ratio (95%CI) P value Odds Ratio (95%CI)
SBP (mmHg) 0.218 0.991 (0.977–1) - -
DBP (mmHg) 0.047 0.977 (0.95–1) - -
Heart Rate (bpm) <0.001 0.955 (0.937–0.974) 0.001 0.950 (0.920–0.970)
Peak Troponin <0.001 0.993 (0.989–0.997) 0.041 0.995 (0.991–0.998)
CK MB 0.065 0.999 (0.997–1) - -
LAD/no LAD NS - - -
Age (years) 0.077 0.97 (0.94–1) - -
Sex (male) 0.200 1.68 (0.78–3.72) - -
Time to PCI 0.041 0.998 (0.996–1) - -
TIMI pre PCI 0.200 1.2 (0.9–1.6) - -
TIMI post PCI 0.147 2.1 (0.77–5.73) - -
Hypertension NS - - -
Diabetes NS - - -
Hyperlipemia NS - - -
Smoke habit NS - - -
Angina NS - - -
Family history of CAD NS - - -
MVO presence <0.001 0.341 (0.188–0.619) <0.001 0.2 (0.075–0.537)
SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; CK MB = Creatine Kinase Myocardial Band; LAD = Left Anterior Descending Coronary
Artery; TIMI = Thrombolysis In Myocardial Infarction; PCI = Percutaneous Coronary Angioplasty; CAD = Coronary Artery Disease MVO = Microvascular
Obstruction
doi:10.1371/journal.pone.0145495.t003
Table 4. Average values of cardiac magnetic resonance parameters in anterior vs. non-anterior
infarction.
Variable Groups (n = 187 patients) P values
LAD (n = 85) No-LAD (n = 102)
Area at Risk (%LV) 32±17 25±14 0.002
Infarct Size (%LV) 19±13 15±11 0.015
Myocardial Salvage Index 0.40±0.21 0.42±0.24 0.672
LVEF 47±8.8 50±8.7 0.018
Abbreviations as in previous tables
doi:10.1371/journal.pone.0145495.t004
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Discussion
In the present study, we described, for the first time in human beings, benefits in terms of myo-
cardial salvage associated with a lower heart rate in patients with successfully reperfused
STEMI. Noninvasive myocardial tissue characterization provided by CMR enabled us to differ-
entiate reversible and irreversible myocardial injury (myocardium at risk and myocardial
infarction, respectively) and consequently to determine the presence and extent of salvaged
myocardium. Major findings of this study are as follows: 1) Progressive reduction in myocar-
dial salvage is present as heart rate increases during the occlusion-phase 2) Site of the lesion is
associated with the extent of the area at risk and infarct size but not related to myocardial sal-
vage. These results were observed irrespective of any other known factors influencing myocar-
dial salvage, such us time to reperfusion [22], presence of microvascular obstruction, infarct
size, gender [14], pre-infarction angina [23] and TIMI score pre-PCI [24].
Heart Rate and Necrotic Wave Progression
Other than defining the “wavefront phenomenon”, Reimer and Jennings [1] were also able to
describe how it could be stopped by reperfusion and influenced in its progression by other fac-
tors [25]. Maroko et al. [4] observed that when heart rate rise-up after pacing or isoproterenol,
during LAD occlusion, a higher ST-segment elevation was present. Moreover Przyklenk et al.
[5] demonstrated, during experimental coronary occlusion, higher percentage of area at risk
becoming necrotic as heart rate increases. Heart rate seemed to be able to influence the pro-
gression of the necrotic wave. It was hypothesized that a reduction of diastolic time at high
heart rates may reduce blood flow from collateral vessels and increase oxygen consumption.
Both factors leaded to a less amount of salvaged myocardium [5]. On this rationale, several
studies were carried out testing drugs being able to reduce heart rate in order to slow down the
spreading of the necrosis. Reimer and Jennings [26] were also able to achieve an improvement
in myocardium salvage through the administration of propranolol in dogs after circumflex cor-
onary artery ligation. More than three decades later the paradigm “slow the heart rate to pre-
serve myocardium viability” has remained valid, as showed by recent studies in which the
administration of drugs able to reduce heart rate and oxygen consumption were able to
improve myocardial salvage in animal models of reperfused myocardial infarction [6, 27].
Heart rate reduction by Ivabradine appears to have a positive effect on coronary collateral func-
tion in patients with chronic stable coronary artery disease [28]. Taken all together these obser-
vations suggest that higher heart rate is also a cause, rather than only a consequence, of a wider
myocardial injury during the coronary artery occlusion.
Coherently with observations in animals, in our study we found a constant reduction of
myocardial salvage as heart rate, registered at the admission before reperfusion, increased. At
multivariate analysis, even when correcting for every known factors influencing myocardial
salvage, heart rate remains an independent predictor of myocardial salvage. The result rein-
forces the hypothesis that high heart rate is able to accelerate the progression of the necrotic
wave, facilitating necrosis in ischemic but still viable cells, by exposing them to a higher meta-
bolic demand and to a lower perfusion through collateral circulation. We found no significant
changes in IS between the groups. On the other hand, the final infarct extent is influenced by
several factors other than the spreading of necrosis within the area at risk. In particular, the
extent of the bed of perfusion of the culprit vessel is one of its major determinants, since AAR
accounts for 70% of the variability in the extent of myocardial necrosis [25]. Although not sta-
tistically significant, variability in AAR extent between groups was present, due to a significant
difference in anterior infarcts frequency. These factors could be important confounders when
taking into account infarct size, but less important when measuring myocardial salvage. In our
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patients, and in accordance with our previous report [29], MSI was independent of culprit
lesion site. On the opposite, AAR and IS largely vary in relation to the site of the lesion; conse-
quently MSI can be considered a better index of the progression of the necrotic wave and a bet-
ter surrogate end-point in testing novel reperfusion strategies, as already proposed[2, 3].
For the first time CMR allowed us to non-invasively verify in humans these results by mea-
surement of both AAR and IS in vivo, and from their difference the amount of the salvaged
myocardium. Notably, these measurements can be obtained in a single exam performed
between one to five days after the infarction.
Clinical Implications
Heart rate has been considered for years as an important prognostic factor, being able to pre-
dict both all-cause-mortality and cardiovascular mortality [30], either in patients with stable
coronary artery disease and left ventricular dysfunction [31] or with heart failure [32]. In
patients with acute coronary syndrome, heart rate at discharge has been found to be related to
the mortality at follow-up [33, 34]. Moreover, Parodi et al. [35] observed that heart rate at pre-
sentation80 bpm, in patients with STEMI undergoing primary PCI, was able to predict mor-
tality at a 6 months follow-up. Despite these evidences, it is not yet demonstrated whether in
the context of acute coronary syndrome, heart rate can be also considered as a risk factor other
than a marker of risk. In our study, we observed for the first time in humans how higher heart
rates were related to wider injuries in the myocardium, linking what observed in animals at the
bench of the laboratory with the poor clinical outcomes observed at the bedside. Though
recently introduced, MSI has been proved to be an important prognostic marker, being able to
predict not only mortality but also early ST-segment normalization and left ventricular remod-
eling in patients with reperfused STEMI: a reduction in salvaged myocardium is related to a
worsening of prognosis [2, 3]. Leading to a reduction in myocardial salvage, higher heart rate
could partially explain the higher mortality rate observed. Moreover, it could be proposed that
lowering heart rate during the progression of the necrotic wave could be useful to preserve
myocardium viability within the AAR, and consequently improve prognosis. On these basis a
trial was recently conducted [36], administrating Ivabradine in patients with STEMI undergo-
ing PPCI. Safety and tolerability were positively assessed, but it failed to show a significant
reduction in IS. However, the drug was administered after reperfusion, probably minimizing
possible benefits. Moreover, the amount of salvaged myocardium was not measured.
Study Limitations
Even though the number of patients included in this study is quite large, our preliminary data
needed to be confirmed by larger multicenter trails aiming to definitively demonstrate the
independent role of heart rate on myocardial salvage extent. In particular, the absence of signif-
icant differences in MVO extent between groups should be confirmed in a larger population.
Time to reperfusion is a stronger determinant of myocardial salvage and of the final extent of
infarct size, however in a selected population treated according to the current guidelines (mean
time from symptom onset to reperfusion was 152±149 min in our study population), also the
basal heart rate has a strong importance. CMR studies were performed from day 4 to 5 after
the infarction. A recent experimental study [37] showed the amount of edema may be variable
soon after myocardial infarction as edematous reaction almost disappears 24h after reperfusion
and progressively reappears till a maximum on day 7. However, by the study design the authors
did not correlate the area at risk with the extension of CMR-visualized edema, thus any conclu-
sions in this regard are speculative. Conversely several clinical and experimental studies [2, 3,7,
8, 16–19, 21–24, 38] strongly support the hypothesis that water content, as assessed by and
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T2w-STIR sequences, in the first week after acute myocardial infarction reflects the area at risk
in humans. Future studies will need to better address this point. Unstable patients (Killip class
III-IV) and unsuccessful revascularized patients were excluded from this study, therefore the
results of this paper may not be extended to the general population with acute myocardial
infarction. Finally, in this study CMR was performed as part of a research protocol and did not
contribute to the care of patients.
Conclusion
In the present study we observed that high heart rates registered before performing coronary
angioplasty in timely reperfused patients with STEMI are associated with a reduction in sal-
vaged myocardium. In particular, salvaged myocardium significantly reduced when heart rate
at presentation is85 bpm. Possible benefits in therapy able to reduce heart rate in such a clin-
ical setting should be hypothesized.
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